Back
Eli Lilly and 10K Form
Buy
79
LLY
Eli Lilly and
Last Price:
557.11
Seasonality Move:
2.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LLY News And Ratings
See the #1 stock for the next 7 days that we like better than LLY
LLY Financial Statistics
Sales & Book Value
| Annual Sales: | $28.54B |
|---|---|
| Cash Flow: | $-204.4M |
| Price / Cash Flow: | 156.77 |
| Annual Sales: | $11.65 |
| Price / Book: | 47.8 |
Profitability
| EPS (TTM): | 7.08930 |
|---|---|
| Net Income (TTM): | $6.5B |
| Gross Margin: | $21.91B |
| Return on Equity: | 63.06% |
| Return on Assets: | 12.89% |
Eli Lilly and Earnings Forecast
Key Eli Lilly and Financial Ratios
- The Gross Profit Margin over the past 39 years for LLY is 76.77%.
- The Selling, General & Administrative Expenses for LLY have been equal to 21.26% of Gross Profit Margin.
- The Research & Development expenses have been 25.19% of Revenue.
- The Interest Expense is 5.31% of Operating Income.
- The Net Earning history of LLY is 21.88% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 23 years.
Eli Lilly and Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | LLY |
| CUSIP: | 532457 |
| Website: | lilly.com |
Debt
| Debt-to-Equity Ratio: | 1.7 |
|---|---|
| Current Ratio: | 1.13 |
| Quick Ratio: | 0.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 80.74 |
|---|---|
| Forward P/E Ratio: | 44.61 |
LLY Technical Analysis vs Fundamental Analysis
Buy
79
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy or a Sell?
-
Eli Lilly and stock is rated a Buy
The current Eli Lilly and [LLY] share price is $557.11. The Score for LLY is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.